Heartflow, Inc. (HTFL)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Heartflow, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 46.8% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- -0.22 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.52 | – | 35 | – | -94.30 | -14 | -14 |
| 2025: Q1 | -0.51 | – | 37 | 38.60 | -86.90 | -13 | -14 |
| 2025: Q2 | -0.11 | – | 43 | 39.80 | -21.20 | -27 | -28 |
| 2025: Q3 | -0.63 | – | 46 | 40.50 | -109.90 | -3 | -4 |
| 2025: Q4 | -0.07 | – | 49 | 40.50 | -49.70 | -11 | -13 |
| 2026: Q1 | -0.07 | – | 53 | 41.30 | -52.10 | -30 | -32 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
HeartFlow, Inc., ein Medizintechnikunternehmen, bietet nicht-invasive Lösungen zur Diagnose und Behandlung von Koronarerkrankungen in den USA und weltweit an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 843 |
| Headquarters | San Francisco, CA |
| Website | heartflow.com |
| IPO Date | 8. Aug 2025 |
Management
| Name | Title | Birth Year |
|---|---|---|
| John C.M. Farquhar | President, CEO & Director | 1973 |
| Vikram Verghese C.F.A. | Chief Financial Officer | 1985 |
| Campbell D.K. Rogers FACC, M.D. | Chief Medical Officer & Executive VP | 1961 |
| John Henry Stevens M.D. | Co-Founder | 1961 |
| Kathleen Carey | Senior Vice President of Operations | – |
| Mhairi L. Jones | Chief Accounting Officer | – |
| Justin Cambra | Chief Technology Officer | – |
| Nicholas S. Laudico | Vice President of Investor Relations | – |
| Angela Ahmad J.D. | Chief Legal & Compliance Officer | – |
| Shivanth Bhaskaran | Chief Commercial Operations & Customer Success Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Farquhar John C.M. | Chief Executive Officer | Other | 9,737 | 9.58 | 93,280 |
| 30. Jul 2026 | Farquhar John C.M. | Chief Executive Officer | Other | 18,694 | 2.22 | 41,501 |
| 30. Jul 2026 | Farquhar John C.M. | Chief Executive Officer | Other | 2,789 | 8.33 | 23,232 |
| 27. Jul 2026 | Verghese Vikram | Chief Financial Officer | Other | 22,522 | 2.22 | 49,999 |
| 24. Jul 2026 | Lightcap Jeffrey C | Director | Other | 47,420 | 19.00 | 900,980 |
| 21. Jul 2026 | Verghese Vikram | Chief Financial Officer | Other | 22,522 | 2.22 | 49,999 |
| 17. Jul 2026 | Barabe Timothy C | Director | Other | 5,000 | 19.00 | 95,000 |
| 15. Jul 2026 | Rogers Campbell | Chief Medical Officer | Sell | 9,219 | 25.72 | 237,113 |
| 15. Jul 2026 | Rogers Campbell | Chief Medical Officer | Other | 9,219 | 19.00 | 175,161 |
| 10. Jul 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | 27.75 | 626,096 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.